Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLC

Дата публикации: 20-08-2026 10:07:18

An article created on 2026-08-20 10:07:18

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Time to Sustained CEA Elevation From Start of First-Line Therapy Predicts Initial Treatment Efficacy and Clinical Outcomes in Lung Adenocarcinoma	0	17.69	20-08-2026
2	Immunogenicity evaluation of mutant peptides identified from lung cancer patients	0	16.25	20-08-2026
3	Mapping the Stemness Landscape of Glioblastoma to Drive Heterogeneity and Drug Resistance: Bridging Pathological Omics with Prognostic Outcomes	0	14.17	20-08-2026
4	Sex-Associated Plasma Cell-Free DNA Methylation Patterns in Indonesian Lung Cancer: An Exploratory Study	0	23.93	20-08-2026
5	Identification of Plasma LGALS3BP via Proteomics and Development of a Non-invasive Diagnostic Model for Early-Stage Lung Adenocarcinoma	0	25.78	19-08-2026
6	Establishment and validation of prognostic nomogram for young adults with Non-Metastatic Renal Cell Carcinoma	0	20	20-08-2026
7	NLRP4–ER Stress–CCL5 axis as a translational target for NK cell-based immunotherapy in lung cancer	0	25	19-08-2026
8	The Role of LINC00261 in Pancreatic Cancer Progression: Implications for EMT and FOXA2 Regulation	0	25	20-08-2026
9	The Effect of Early Neutropenia on PFS with Ribociclib Treatment in Advanced Breast Cancer	0	13.78	10-08-2026
10	Clinical Outcomes of Epidermal Growth Factor Receptor (EGFR) Mutated Metastatic Non-Small Cell Lung Cancer in Kurdistan Region: A Retrospective Study	0	17.69	20-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 28.75. Источник: www.researchsquare.com.